Abstract
A polymorphism (Val66Met) in the gene encoding brain-derived neurotrophic factor (BDNF) has previously been associated with impaired hippocampal function and scores on the Logical Memory subtest of the Wechsler Memory Scale-Revised (WMS-R). Despite its widespread expression in the brain, there have been few studies examining the role of BDNF on cognitive domains, other than memory. We examined the association between BDNF Val66Met genotype and non-verbal reasoning, as measured by Raven's standard progressive matrices (Raven), in two cohorts of relatively healthy older people, one aged 79 (LBC1921) and the other aged 64 (ABC1936) years. LBC1921 and ABC1936 subjects had reasoning measured at age 11 years, using the Moray House Test (MHT), in the Scottish Mental Surveys of 1932 and 1947, respectively. BDNF genotype was significantly associated with later life Raven scores, controlling for sex, age 11 MHT score and cohort (P=0.001). MHT, Verbal Fluency and Logical Memory scores were available, in later life, for LBC1921 only. BDNF genotype was significantly associated with age 79 MHT score, controlling for sex and age 11 MHT score (P=0.016). In both significant associations, Met homozygotes scored significantly higher than heterozygotes and Val homozygotes. This study indicates that BDNF genotype contributes to age-related changes in reasoning skills, which are closely related to general intelligence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Accession codes
References
Fillit HM, Butler RN, O’Connell AW, Albert MS, Birren JE, Cotman CW et al. Achieving and maintaining cognitive vitality with aging. Mayo Clin Proc 2002; 77: 681–696.
Deary IJ, Wright AF, Harris SE, Whalley LJ, Starr JM . Searching for genetic influences on normal cognitive ageing. Trends Cogn Sci 2004; 8: 178–184.
Deary IJ, Whiteman MC, Starr JM, Whalley LJ, Fox HC . The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol 2004; 86: 130–147.
Scottish Council for Research in Education. The Intelligence of Scottish children: A National Survey of an Age-Group. University of London Press: London, 1933.
Scottish Council for Research in Education. The Trend of Scottish Intelligence: A Comparison of the 1947 and 1932 Surveys of the Intelligence of Eleven-Year-Old Pupils. University of London Press: London, 1949.
Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF et al. Cognitive change and the APOE epsilon 4 allele. Nature 2002; 418: 932.
Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF et al. Apolipoprotien E gene variability and cognitive functions at age 79: follow up of the Scottish Mental Survey 1932. Psychol Aging 2004; 19: 367–371.
Deary IJ, Hamilton G, Hayward C, Whalley LJ, Powell J, Starr JM et al. Nicastrin gene polymorphisms, cognitive ability level and cognitive ageing. Neurosci Lett 2005; 373: 110–114.
Deary IJ, Harris SE, Fox HC, Hayward C, Wright AF, Starr JM et al. KLOTHO genotype and cognitive ability in childhood and old age in the same individuals. Neurosci Lett 2005; 378: 22–27.
Harris SE, Wright AF, Hayward C, Starr JM, Whalley LJ, Deary IJ . The functional COMT polymorphism, Val158Met, is associated with Logical Memory and the personality trait intellect/imagination in a cohort of healthy 79 year olds. Neurosci Lett 2005; 385: 1–6.
Kachiwala SJ, Harris SE, Wright AF, Hayward C, Starr JM, Whalley LJ et al. Genetic influences on oxidative stress and their association with normal cognitive ageing. Neurosci Lett 2005; 386: 116–120.
Thomson PA, Harris SE, Starr JM, Whalley LJ, Porteous DJ, Deary IJ . Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci Lett 2005; 389: 41–45.
Tapia-Arancibia L, Rage F, Givalois L, Arancibia S . Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 2004; 25: 77–107.
Murer MG, Yan Q, Raisman-Vozari R . Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001; 63: 71–124.
Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD . From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 2002; 9: 224–237.
Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 2004; 101: 10827–10832.
Mattson MP, Chan SL, Duan W . Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 2002; 82: 637–672.
Hayashi M, Mistunaga F, Ohira K, Shimizu K . Changes in BDNF-immunoreactive structures in the hippocampal formation of the aged macaque monkey. Brain Res 2001; 918: 191–196.
Lee J, Duan W, Mattson MP . Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 2002; 82: 1367–1375.
Mowla SJ, Farhadi HF, Pareek S, Atwal JK, Morris SJ, Seidah NG et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 2001; 276: 12660–12666.
Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257–269.
Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003; 23: 6690–6694.
Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24: 4401–4411.
Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24: 10099–10102.
Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S et al. Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005; 10: 631–636.
Dempster E, Toulopoulou T, McDonald C, Bramon E, Walshe M, Filbey F et al. Association between BDNF val66 met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 73–75.
Tsai SJ, Hong CJ, Yu YW, Chen TJ . Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 2004; 49: 13–16.
Petrill SA, Lipton PA, Hewitt JK, Plomin R, Cherny SS, Corley R et al. Genetic and environmental contributions to general cognitive ability through the first 16 years of life. Dev Psychol 2004; 40: 805–812.
Petrill SA, Plomin R, Berg S, Johansson B, Pedersen NL, Ahern F et al. The genetic and environmental relationship between general and specific cognitive abilities in twins age 80 and older. Psychological Science 1998; 9: 183–189.
Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M . Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 2000; 76: 347–354.
Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M . Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 1997; 49: 71–81.
Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW . BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991; 7: 695–702.
Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 1999; 58: 729–739.
Ventriglia M, Bocchio CL, Benussi L, Binetti G, Zanetti O, Riva MA et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 2002; 7: 136–137.
Matsushita S, Arai H, Matsui T, Yuzuriha T, Urakami K, Masaki T et al. Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J Neural Transm 2005; 112: 703–771.
Bodner SM, Berrettini W, van DV, Bennett DA, Wilson RS, Trojanowski JQ et al. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 1–5.
Nacmias B, Piccini C, Bagnoli S, Tedde A, Cellini E, Bracco L et al. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett 2004; 367: 379–383.
Combarros O, Infante J, Llorca J, Berciano J . Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 18: 55–58.
Bagnoli S, Nacmias B, Tedde A, Guarnieri BM, Cellini E, Petruzzi C et al. Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy. Ann Neurol 2004; 55: 447–448.
Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE, Lin CH . Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology 2004; 49: 10–12.
Bian JT, Zhang JW, Zhang ZX, Zhao HL . Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese. Neurosci Lett 2005; 387: 11–16.
Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ et al. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 93–103.
Dias BG, Banerjee SB, Duman RS, Vaidya VA . Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 2003; 45: 553–563.
Garzon D, Yu G, Fahnestock M . A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochem 2002; 82: 1058–1064.
Visscher PM, Tynan M, Whiteman MC, Pattie A, White I, Hayward C et al. Lack of association between polymorphisms in angiotensin-converting-enzyme and methylenetetrahydrofolate reductase genes and normal cognitive ageing in humans. Neurosci Lett 2003; 347: 175–178.
Whalley LJ, Fox HC, Starr JM, Deary IJ . Age at natural menopause and cognition. Maturitas 2004; 49: 148–156.
Whalley LJ, Fox HC, Deary IJ, Starr JM . Childhood IQ, smoking, and cognitive change from age 11 to 64 years. Addictive Behaviors 2005; 30: 77–88.
Folstein MF, Folstein SE, McHugh PR . ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
Deary IJ, Whalley LJ, Lemmon H, Crawford JR, Starr JM . The stability of individual differences in mental ability from childhood to old age: follow-up of the 1932 Scottish Mental Survey. Intelligence 2000; 28: 49–55.
Raven JC, Court JH, Raven J . Manual for Raven's Progressive Matrices and Vocabulary Scales. H.K. Lewis: London, 1977.
Carroll JB . Human Cognitive Abilities: A Survey of Factor Analytic Studies. Cambridge University Press: Cambridge, 1993.
Lezak M . Neuropsychological Testing. Oxford University Press: Oxford, England, 1995.
Boone KB, Ponton MO, Gorsuch RL, Gonzalez JJ, Miller BL . Factor analysis of four measures of prefrontal lobe functioning. Arch Clin Neuropsychol 1998; 13: 585–595.
Wechsler D . Wechsler Memory Scale-Revised. Psychological Corporation: New York, 1987.
Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 2001; 6: 83–86.
Kanemoto K, Kawasaki J, Tarao Y, Kumaki T, Oshima T, Kaji R et al. Association of partial epilepsy with brain-derived neurotrophic factor (BDNF) gene polymorphisms. Epilepsy Res 2003; 53: 255–258.
Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002; 7: 579–593.
Batty GD, Deary IJ . Early life intelligence and adult health. BMJ 2004; 329: 585–586.
Salthouse TA, Ferrer-Caja E . What needs to be explained to account for age-related effects on multiple cognitive variables? Psychol Aging 2003; 18: 91–110.
Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Muller U, Forstl H et al. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry 2002; 7: 782–785.
Acknowledgements
We thank Martha Whiteman and Alison Pattie who collected phenotype data on the LBC1921 subjects. We thank Jen Herbert and others who collected phenotype data on the ABC1936 subjects. This project was funded by the United Kingdom Biotechnology and Biological Sciences Research Council. Ian Deary holds a Royal Society-Wolfson Research Merit award.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on Molecular Psychiatry website (http://www.nature.com/mp)
Supplementary information
Rights and permissions
About this article
Cite this article
Harris, S., Fox, H., Wright, A. et al. The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol Psychiatry 11, 505–513 (2006). https://doi.org/10.1038/sj.mp.4001799
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001799
Keywords
This article is cited by
-
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer’s Disease
CNS Drugs (2020)
-
Effect of the interaction between BDNF Val66Met polymorphism and daily physical activity on mean diffusivity
Brain Imaging and Behavior (2020)
-
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer’s disease: a 9-year follow-up study
European Archives of Psychiatry and Clinical Neuroscience (2020)
-
BDNF genetic variants and methylation: effects on cognition in major depressive disorder
Translational Psychiatry (2019)
-
Why Enhancing Autonomy Is Not a Question of Improving Single Aspects of Reasoning Abilities through Neuroenhancement
Neuroethics (2017)